^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Head and Neck Cancer
    Drug:cisplatin (DNA synthesis inhibitor) +
    pemetrexed (Thymidylate synthase inhibitor, THF dehydrogenase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Useful in Certain Circumstances:….: Cisplatin/pemetrexed (for PS 0-1) (category 2B)